oncology drug development and dose optimization: what are the implications of project optimus?
Published 8 months ago • 285 plays • Length 14:30Download video MP4
Download video MP3
Similar videos
-
42:27
what you should know about fda project optimus for your oncology drug approval
-
59:00
what is fda project optimus and how will it impact oncology drug development?
-
1:05:36
project optimus – fda’s new dose optimization & selection paradigm in oncology drug development
-
54:26
what oncology drug developers should expect from the fda’s project optimus
-
1:00:38
project optimus- reimagining oncology drug development with dose optimization
-
4:11
the making of insilico's ai-powered robotics lab
-
4:15
how ai is accelerating drug discovery
-
1:03:31
application of artificial intelligence ai & machine learning ml in pharmaceutical industry
-
12:07
the fda’s "project optimus" and oncology drugs
-
31:44
echalk talk: how oncology drug developers can prepare for fda’s project optimus
-
57:36
project optimus & pediatric drug development
-
1:28:43
modeling and simulation to select oncology dosages - session 1
-
29:20
fda oncology drug development overview – past to present
-
0:49
precision oncology: radionuclide conjugate and antibody-drug conjugate (adc) development strategies
-
58:59
future in focus: digital pathology in oncology drug development
-
49:35
quantitative and systems pharmacology approaches for the development of oncology drugs
-
58:13
dose optimization for anti-cancer agents in the era of immunotherapy and targeted agents
-
1:14:48
oncology drug modalities: a new era in oncology drug development
-
6:18
importance of patient provider discussions about oncology dose optimization
-
11:35
2022 nhpdd day 1, session 2, part 3
-
1:02:13
how to better optimize an oncology drug discovery program
-
35:06
oncology drug development in the era of precision medicine: fda perspective